| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D307-93
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-343
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20 |
| filingDate |
2002-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8d9939ba6f7c68e4119cde6edd957e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d10c7a636dbf34d31c9e981af3b0b914
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24558dda309d449a138ff6176f71072d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab439417f8e21ee0ce773bff444a8464
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a24ef79f944d14508e03abe053a1dab |
| publicationDate |
2005-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
HU-0402224-A2 |
| titleOfInvention |
New mandelate salts of substituted tetracyclic tetrahydrofuran derivatives |
| abstract |
The present invention relates to the mandelate salt, the N-oxide forms and the stereochemically isomeric forms thereof of the compound of formula I wherein R 1 and R 2 are independently hydrogen or C 1-6 alkyl, R 3 and R 4 are independently hydrogen or halogen; A C 6 alkyl group is a straight or branched saturated hydrocarbon group having from 1 to 6 carbon atoms. The novel mandelate salts of the present invention are non-photosensitive and more stable than other salts known in the art at room temperature and at elevated temperatures as well as in high humidity environments and aqueous media. The present invention relates to pharmaceutical compositions for the preparation of mandelate salts and for the treatment of central nervous system disorders, cardiovascular disorders and gastrointestinal disorders. HE |
| priorityDate |
2001-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |